Benzene metabolism in human lung cell lines BEAS-2B and A549 and cells overexpressing CYP2F1

Journal of Biochemical and Molecular Toxicology

Volumn 18, Issue 2, 2004, Pages 92-99

  Sheets, Patrick L ^a   Yost, Garold S ^b   Carlson, Gary P ^a  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Benzene; Cytochromes P450; Liver; Lung

Indexed keywords

5 PHENYL 1 PENTYNE; BENZENE; CYTOCHROME P450; CYTOCHROME P450 2E1; CYTOCHROME P450 2F1; CYTOCHROME P450 INHIBITOR; DIETHYLDITHIOCARBAMIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA; LUNG ALVEOLUS CELL; LUNG DISEASE; METABOLISM;

ALKYNES; BENZENE; BENZENE DERIVATIVES; CELL LINE; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; DITIOCARB; ENZYME INHIBITORS; GENE EXPRESSION; HUMANS; KINETICS; LUNG; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 2342663701     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.20010     Document Type: Article

References (32)

1. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for benzene. Atlanta, GA: US Department of Health and Human Services, Public Health Service; 1997.
2. Infante PF, Rinsky RA, Wagoner JK, Young RJ. Leukemia in benzene workers. Lancet 1977;19:407-421.
3. Aksoy M. Different types of malignancies due to occupational exposure to benzene in Turkey. Environ Res 1980;23:181-190.
4. Aksoy M. Problems with benzene in Turkey. Reg Toxicol Pharmacol 1981;1:147-155.
5. Aksoy M. Benzene as a leukemongenic and carcinogenic agent. Am J Ind Med 1985;8:9-20.
6. 1 mice. Env Health Persp 1989;82: 125-163.
7. Orzechowski A, Schwarz LR, Schwegler U, Bock KW, Synder R, Schrenk D. Benzene metabolism in rodent hepatocytes: Role of sulphate conjugation. Xenobiotica 1995;10:1093-1102.
8. Guengerich FP. Human Cytochrome P450 Enzymes. Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd edition. New York: Plenum Press; 1995. pp 473-535.
9. Jerina A, Daly J, Witkop B, Zaltzman-Nirenberg P, Udenfriend S. Role of the arene oxide-oxepin system in the metabolism of aromatic substances. I. In-vitro conversion of benzene oxide to a premercapturic acid and dihydrodiol. Arch Biochem Biophys 1968;128: 176-193.
10. Sawahata T, Neal RA. Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes. Mol Pharmacol 1983;23:453-460.
11. Bauer AK, Faiola B, Abernethy DJ, Marchan R, Pluta LJ, Wong VA, Roberts K, Jaiswal AK, Gonzalez FJ, Butterworth BE, Borghoff SJ, Parkinson H, Everitt JI, Recio L. Genetic susceptibility to benzene-induced toxicity: Role of NADPH: quinone oxidoreductase-1. Cancer Res 2003;63:929-935.
12. Valentine JL, Lee SST, Seaton MJ, Asgharian B, Farris G, Corton, JC, Gonzalez FJ, Medinsky MA. Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol Appl Pharmacol 1996;141:205-213.
13. Koop DR, Laethem CL, Schnier GG. Identification of ethanol-inducible P450 isoenzyme 3a (P450 IIE1) as a benzene and phenol hydroxylase. Toxicol Appl Pharmacol 1989;98:278-288.
14. Masuda Y, Nakayama N, Yamaguchi A, Murohashi, M. The effects of diethyldithiocarbamate and carbon disulfide on acute nephrotoxicity induced by furan, bromobenzene, and cephaloridine in mice. Jpn J Pharmacol 1984;34:221-229.
15. Gut I, Nedelcheva V, Soucek P, Stopka P, Vodicka P, Gelboin HV, Ingelman-Sundberg M. The role of CYP2E1 and 2B1 in metabolic activation of benzene derivatives. Arch Toxicol 1996;71:45-56.
16. Chaney AM, Carlson GP. Comparison of rat hepatic and pulmonary microsomal metabolism of benzene and the lack of benzene-induced pneumotoxicity and hepatotoxicity. Toxicology 1995;104:53-62.
17. Powley MW, Carlson GP. Cytochromes P450 involved with benzene metabolism in hepatic and pulmonary microsomes. J Biochem Mol Toxicol 2000;4:303-309.
18. Sheets PL, Carlson GP. Kinetic factors involved in the metabolism of benzene in the mouse lung and liver. J Toxicol Environ Health Part A 2004;67:421-430.
19. Carr BA, Wan J, Hines RN, Yost GS. Characterization of the human lung CYP2F1 gene and identification of a novel lung-specific binding motif. J Biol Chem 2003;278:15473-15483.
20. Lanza DL, Code E, Crespi CL, Gonzalez FJ, Yost GS. Specific dehydrogenation of 3-methylindole and epoxidation. of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells. Drug Metab Dispos 1999;27:798-803.
21. Nichols WK, Mehta R, Skordos K, Macé K, Pfeifer AMA, Carr BA, Minko T, Burchiel SW, Yost GS. 3-Methyindole-induced toxicity to human bronchial epithelial cell lines. Toxicol Sci 2003;71:229-236.
22. Anttila S, Hukkanen J, Hakkola J, Stjernvall T, Beaune P, Edwards RJ, Boobis AR, Pelkonen O, Raunio H. Expression and localization of CYP3A4 and CYP3A5 in human lung. Am J Respir Cell Mol Biol 1997;16:242-249.
23. Willey JC, Coy EL, Frampton MW, Torres A, Apostolakos MJ, Hoehn G, Schuermann WH, Thilly WG, Olson DE, Hammersley JR, Crespi CL, Utell MJ. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am J Respir Cell Mol Biol 1997;17: 114-124.
24. Hukkanen J, Pelkonen O, Hakkola J, Raunio H. Expression and regulation of xenobiotic metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol 2002;32:391-411.
25. Nichols WK, Terry CM, Cutler NS, Appleton ML, Jesthi PK, Yost GS. Oxidation at C-1 controls the cytotoxicity of 1,1-dichloro-2,2-bis (p-chlorophenyl) ethane by rabbit and human lung cells. Drug Metab Dispos 1995;23:595-599.
26. Van Agen B, Maas LM, Zingmann IH, Van Schooten F, Kleinjans JCS. B[a]P-DNA adduct formation and induction of human epithelial lung cell transformation. Environ Mol Mutagen 1997;30:287-292.
27. Hukkanen J, Lassila A, Päivärinta K, Valanne S, Sarpo S, Hakkola J, Pelkonen O, Raunio H. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 2000;22:360-366.
28. Foster KA, Oster CF, Mayer MM, Avery ML, Audus KL. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res 1998;243:359-366.
29. Powley MW, Carlson GP. Species comparison of hepatic and pulmonary metabolism of benzene. Toxicology 1999;139:207-217.
30. Powley MW, Carlson GP. Cytochrome P450 isoenzymes involved in the metabolism of phenol, a benzene metabolite. Toxicology Lett 2001;125:117-123.
31. Powley MW, Carlson GP. Hepatic and pulmonary microsomal benzene metabolism in CYP2E1 knockout mice. Toxicology 2001;169:187-194.
32. Carlson GP, Mantick NA, Powley MW. Metabolism of styrene by human liver and lung. J Toxicol Environ Health 2000;59:591-595.